FREE EVENT: AI-driven cancer nanotherapies: from computation to clinic Free workshop about evolutionary artificial intelligence to help design and test nanoparticles as carriers for drug
A joint initiative leaded by board members of SFNano and CRS BeNeLux & France Local Chapter We are pleased to announce a chapter contribution “Nanomedicine for the management of colorectal cancer on the 2030 horizon?” to a book dedicated to clinicians “Colorectal cancer horizon 2030”. This joint initiative leaded by board members of SFNano and CRS BeNeLux & France Local Chapter aimed to attract more clinicians to the nanomedicine field. The book was launched during the French Gastroenterological congress (JFHOD) 2022. The book is available here.
Katalin Karikó, when passion for science and perseverance pay off Chantal PICHON Centre de Biophysique Moléculaire, UPR 4301 CNRS, University of Orléans, Orléans, France Contact: email@example.com In 2021, the field of nanomedicine has seen a real upheaval with the development of mRNA vaccines against SARS-CoV-2, the only positive note in this pandemic. Time for us to pay tribute to Prof Katalin Karikó, a great scientist who honored us with her presence in 2017 at a Summer school (from June 7 to 9, hotel Mercure in the La Grande-Motte beach resort) dedicated to Nucleic acids-based strategies to control gene expression: principles, applications in biology, clinical translation and delivery issues » (https://sfnano.fr/2017/09/01/ecole-dete-2017/). Our acknowledgement to Prof Bernard Lebleu, an eminent board member of SFNano, who invited her to be part of the Summer School. She gave us a great lecture explaining how important the presence of modified nucleosides for mRNA therapeutics applications is.